Recombinant monoclonal antibody specially binds to anthrax toxin. This anti-anthrax toxin antibody 83K7C has therapeutic value in human with anthrax infection.
Figure 1 Analysis of IgG clones selected from the anti-PA library.
Flow cytometry histogram depicting the fluorescence intensity of E. coli clones expressing anti-PA IgG antibodies and labeled with PA-FITC.
Schumacher, W. C., Storozuk, C. A., Dutta, P. K., & Phipps, A. J. (2008). Identification and characterization of Bacillus anthracis spores by multiparameter flow cytometry. Applied and environmental microbiology, 74(16), 5220-5223.
Figure 2 The graph shows the association between toxin-neutralising antibody titres (x-axis) and protective antigen.
The horizontal dashed lines indicate cut-off values for PA- and LF-specific immunoglobulin levels that discriminate between samples positive or negative for toxin-neutralising antibodies, as determined by receiver operator curve analysis.
Grunow, R., Porsch-Özcürümez, M., Splettstoesser, W., Buckendahl, A., Hahn, U., Beyer, W., ... & Frangoulidis, D. (2007). Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccine. Vaccine, 25(18), 3679-3683.
Figure 3 The graph shows the time course of toxin-neutralising antibody titres, protective antigen-specific immunoglobulins.
The time frame and median of the corresponding blood samples are shown on the x-axis.
Grunow, R., Porsch-Özcürümez, M., Splettstoesser, W., Buckendahl, A., Hahn, U., Beyer, W., ... & Frangoulidis, D. (2007). Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccine. Vaccine, 25(18), 3679-3683.
Figure 4 Abundant immunohistochemical staining of granular and bacilliform antigens were demonstrated in the dermis by using anti-B. anthracis cell wall antibody.
Original magnifications: ×100.
Shieh, W. J., Guarner, J., Paddock, C., Greer, P., Tatti, K., Fischer, M., ... & Popovic, T. (2003). The critical role of pathology in the investigation of bioterrorism-related cutaneous anthrax. The American journal of pathology, 163(5), 1901-1910.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
NAB-194-VHH | Recombinant Anti-B. anthracis PA VHH Single Domain Antibody | WB, ICC, ChiP, FA, ELISA | Llama VHH |
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-97 | Recombinant Anti-B. anthracis PA Antibody | ELISA, IF, FuncS | IgG |
MHH-97 | Recombinant Human Anti-B. anthracis PA Antibody | Neut, IF, FuncS | IgG |
HPAB-0747-YJ | Human Anti-B. anthracis PA Recombinant Antibody (W1) | ELSIA, Neut | Chimeric (chimpanzee/human) IgG1, κ |
HPAB-0748-YJ | Human Anti-B. anthracis PA Recombinant Antibody (W2) | ELSIA, Neut | Chimeric (chimpanzee/human) IgG1, κ |
FAMAB-0333JF | Human Anti-B. anthracis PA Recombinant Antibody (clone 001.46F1) | ELISA, IHC | Human IgG1, κ |
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-97-S(P) | Recombinant Anti-B. anthracis PA Antibody scFv Fragment | WB, FC, FuncS | scFv |
MHH-97-S(P) | Recombinant Human Anti-B. anthracis PA Antibody scFv Fragment | Neut, WB, FuncS | scFv |
HPAB-1646-FY-F(E) | Human Anti-B. anthracis PA Recombinant Antibody; Fab Fragment (HPAB-1646-FY-F(E)) | ELISA | Human Fab |
HPAB-1647-FY-F(E) | Human Anti-B. anthracis PA Recombinant Antibody; Fab Fragment (HPAB-1647-FY-F(E)) | ELISA | Human Fab |
HPAB-1648-FY-F(E) | Human Anti-B. anthracis PA Recombinant Antibody; Fab Fragment (HPAB-1648-FY-F(E)) | ELISA | Human Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-224 | Anti-B. Anthracis Anthrax Protective Antigen (Raxibacumab) | FC, IP, ELISA, Neut, FuncS, IF, WB | IgG1 - lambda |
CAT | Product Name | Application | Type |
---|---|---|---|
EPAF-0387LC | Recombinant Mouse Anti-B. anthracis PA Antibody (F20G75) | BL, ELISA | IgG1 |
CAT | Product Name | Application | Type |
---|---|---|---|
AFC-TAB-224 | Afuco™ Anti-B. anthracis PA ADCC Recombinant Antibody (Raxibacumab), ADCC Enhanced | FC, IP, ELISA, Neut, FuncS, IF | ADCC enhanced antibody |
AFC-TAB-440CQ | Afuco™ Anti-PA ADCC Recombinant Antibody (Obiltoxaximab), ADCC Enhanced | ELISA, IHC, FC, IP, IF, FuncS | ADCC enhanced antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
HPAB-1824-FY-S(P) | Human Anti-B. anthracis PA Recombinant Antibody (clone 21D9); Fab Fragment | ELISA | Human Fab |
HPAB-1825-FY-S(P) | Human Anti-B. anthracis PA Recombinant Antibody (clone 1C6); Fab Fragment | ELISA | Human Fab |
HPAB-0747-YJ-F(E) | Human Anti-B. anthracis PA Recombinant Antibody (W1); Fab Fragment | ELISA, Neut | Chimeric (chimpanzee/human) Fab |
HPAB-0748-YJ-F(E) | Human Anti-B. anthracis PA Recombinant Antibody (W2); Fab Fragment | ELISA, WB, Neut, FuncS | Chimeric (chimpanzee/human) Fab |
FAMAB-0333JF-F(E) | Human Anti-B. anthracis PA Recombinant Antibody (clone 001.46F1); Fab Fragment | ELISA, FuncS | Human Fab |
There are currently no Customer reviews or questions for FAMAB-0048JF. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.